Basket | Login

 
 
 
 

Clinical trials by country

Phase II trials

Belgium

  1. GRADUATION

Czech Republic

  1. ALZ-801
  2. T-817MA

Denmark

  1. VIVIAD

Germany

  1. GRADUATION
  2. T-817MA
  3. VIVIAD

Finland

  1. ACI-24-1801
  2. ACI-35.030

France

  1. GRADUATION (planned)

Hungary

  1. T-817MA

Netherlands

  1. ACI-35.030
  2. ALZ-801
  3. T-817MA
  4. TRAILBLAZER-ALZ 2 (planned)
  5. VIVIAD

Italy

  1. GRADUATION (planned)

Poland

  1. ACI-24-1801 (planned)
  2. GRADUATION
  3. TRAILBLAZER-ALZ 2

Spain

  1. GRADUATION (planned)
  2. T-817MA

Sweden

  1. ACI-24-1801

UK

  1. ACI-24-1801
  2. ACI-35.030 (planned)
  3. DESPIAD
  4. GRADUATION
  5. T-817MA

 

 
 

Last Updated: Monday 18 January 2021

 

 
  • Acknowledgements

    Alzheimer Europe's Clinical Trial Watch received funding under an operating grant from the European Union’s Health Programme (2014–2020).
  • European Union
 
 

Options